SKU: E090  / 
    CAS Number: 56420-45-2

    Epirubicin Hydrochloride

    ₹19,985.43 - ₹69,458.57
    • Detailed Description

      CAS Number: 56420-45-2

      Molecular Formula: C27H29NO11.HCl

      Molecular Weight: 580.0

      Tariff Code: 3822.00.5090

    • Specifications

      Form: Solid

      Appearance: Red solid

      Source: Synthetic

    • Technical Data

      Solubility: Soluble in methanol or DMSO

    • References

      References:

      Goldin A et al (1985)  The effectiveness of the anthracycline analog 4’-epidoxorubicin in the treatment of experimental tumors: A review. Invest New Drugs 3:3

      Nitiss JL (2009)  Targeting DNA topoisomerase II in cancer chemotherapy. Nat. Rev. Cancer 9:338

      Pang B et al (2013)  Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin.  Nature Comm. 2013, DOI:10:1038/ncomms 2921

    Epirubicin is the 4'-epi-isomer of the antitumor agent, doxorubicin. Epirubicin acts by inhibiting topoisomerase II resulting in DNA double strand breaks. The anthracyclines also act by evicing histone from open chromatin, deregulating the transcriptome in cancer cells and organs. Epirubicin is active against a wide spectrum of experimental tumours including L1210 and P388 leukemias, sarcomas SA180 (solid and ascitic forms), B16 melanoma, mammary carcinoma, Lewis lung carcinoma and colon carcinoma 38

     

    CAS Number: 56420-45-2

    Molecular Formula: C27H29NO11.HCl

    Molecular Weight: 580.0

    Tariff Code: 3822.00.5090

    Form: Solid

    Appearance: Red solid

    Source: Synthetic

    Solubility: Soluble in methanol or DMSO

    References:

    Goldin A et al (1985)  The effectiveness of the anthracycline analog 4’-epidoxorubicin in the treatment of experimental tumors: A review. Invest New Drugs 3:3

    Nitiss JL (2009)  Targeting DNA topoisomerase II in cancer chemotherapy. Nat. Rev. Cancer 9:338

    Pang B et al (2013)  Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin.  Nature Comm. 2013, DOI:10:1038/ncomms 2921